| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5898030 | EMD SERONO | hGH containing pharmaceutical compositions |
Apr, 2016
(8 years ago) | |
Saizen is owned by Emd Serono.
Saizen contains Somatropin Recombinant.
Saizen has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Saizen are:
- US5898030
Saizen was authorised for market use on 16 January, 2007.
Saizen is available in injectable;injection dosage forms.
The generics of Saizen are possible to be released after 27 April, 2016.
Drugs and Companies using SOMATROPIN RECOMBINANT ingredient
Market Authorisation Date: 16 January, 2007
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
SAIZEN family patents
